Buddy Roemer: Me, O...
Technology: Electronics
Transgenomic Inc. (TBIO: OTC)
$1.19 -0.10 | -7.75%
02/09/12 - 03:58 PM ET
124.22K / 75.10K
Vol / Avg. Vol:1.25 / 1.29
Open / Prev. Close:1.19 - 1.30
Today's Range:0.66 - 1.85
52 Wk Range:0.00%
Performance YTD:TheStreet Rating:
Portfolios with TBIO
- Portfolio NameUser Type
- UserSHOW ME THE $$$$$
Latest TBIO Headlines from TheStreet
- Biotechs Face New Year Hangover From IPO Overhang 12.26.00 | 11:12 am
Press Releases for TBIO
- Transgenomic Announces $22.0 Million Private Placement Financing - Business Wire 02.03.12 | 08:02 am
- Transgenomic, Inc. And Power3 Medical Products, Inc. Resolve All Outstanding Litigation Proceedings And Disputes - Business Wire 01.09.12 | 11:01 am
- Transgenomic Announces $3 Million Convertible Note Financing - Business Wire 01.06.12 | 10:01 am
- Transgenomic To Present At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.07.11 | 11:12 am
- Transgenomic Expands Cardiology Genetic Test Offerings - Business Wire 11.14.11 | 08:11 am
- Transgenomic Reports Third Quarter Financial Results - Business Wire 11.09.11 | 04:11 pm
- Reminder - Transgenomic To Hold Third Quarter Financial Results Conference Call Today - Business Wire 11.09.11 | 09:11 am
- Transgenomic Announces European Distribution Agreement With A. Menarini Diagnostics For Its WAVE® System And SURVEYOR® Kits - Business Wire 11.07.11 | 09:11 am
- Transgenomic To Hold Third Quarter Financial Results Conference Call On November 9, 2011 - Business Wire 11.02.11 | 10:11 am
- Transgenomic To Present At The Craig-Hallum 2nd Annual Alpha Select Conference - Business Wire 10.04.11 | 09:10 am
Partner Headlines for TBIO
